Home About

buprenorphine hydrochloride and naloxone hydrochloride dihydrate

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE

Manufacturer: Bryant Ranch Prepack

Score: 141.0

Quick Summary

Buprenorphine and Naloxone Sublingual Tablets are used for the maintenance treatment of opioid dependence. The drug contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist. Key clinical findings indicate that the drug is effective in suppressing opioid withdrawal signs and symptoms. Important safety information includes warnings about addiction, abuse, and misuse, as well as contraindications for patients with hypersensitivity to buprenorphine or naloxone. The main dosing recommendation is to administer the drug sublingually as a single daily dose, with a recommended target dosage of 16 mg/4 mg buprenorphine/naloxone per day. Special population considerations include use during pregnancy, nursing mothers, pediatric use, and geriatric use.

Key Clinical Findings and Indications

  • Maintenance treatment of opioid dependence
  • Suppression of opioid withdrawal signs and symptoms
  • Effective in reducing illicit opioid use

Important Safety Information

Warning

Addiction, abuse, and misuse may lead to overdose and death

Contraindications

  • Hypersensitivity to buprenorphine or naloxone

Adverse Reactions

  • Respiratory depression
  • CNS depression
  • Neonatal opioid withdrawal syndrome

Dosing Recommendations

General Guidance

Dosage adjustments may be necessary in patients with hepatic impairment or those taking CYP3A4 inhibitors or inducers

Opioid dependence

Adult Dose

16 mg/4 mg buprenorphine/naloxone per day

Pediatric Dose

Not established

Special Population Considerations

Pregnancy

  • Use during pregnancy may lead to neonatal opioid withdrawal syndrome
  • Dose adjustments may be necessary during pregnancy

Nursing Mothers

  • Caution is advised when administering the drug to nursing mothers

Pediatric Use

  • The safety and effectiveness of the drug have not been established in pediatric patients

Geriatric Use

  • Caution is advised when administering the drug to geriatric patients due to possible decreased hepatic, renal, or cardiac function

Similar Drugs

BUPRENORPHINE

BUPRENORPHINE

Bryant Ranch Prepack

Similarity: 74.9%

Buprenorphine

BUPRENORPHINE

INGENUS PHARMACEUTICALS, LLC

Similarity: 74.9%

Buprenorphine

BUPRENORPHINE

RedPharm Drug, Inc.

Similarity: 74.9%

Buprenorphine

BUPRENORPHINE

Amneal Pharmaceuticals NY LLC

Similarity: 74.9%

BUPRENORPHINE

BUPRENORPHINE

Bryant Ranch Prepack

Similarity: 74.9%

BUPRENORPHINE

BUPRENORPHINE

Bryant Ranch Prepack

Similarity: 74.9%

Buprenorphine

BUPRENORPHINE

AvPAK

Similarity: 74.9%

Buprenorphine

BUPRENORPHINE

Teva Pharmaceuticals USA, Inc.

Similarity: 74.9%

BRIXADI

BUPRENORPHINE

Braeburn Inc.

Similarity: 74.9%

BUPRENORPHINE

BUPRENORPHINE

Bryant Ranch Prepack

Similarity: 74.9%

SUBLOCADE

BUPRENORPHINE

Indivior Inc.

Similarity: 74.9%

Buprenorphine

BUPRENORPHINE

American Health Packaging

Similarity: 74.9%

BUPRENORPHINE

BUPRENORPHINE

Redpharm drug

Similarity: 74.9%

Buprenorphine

BUPRENORPHINE

Actavis Pharma, Inc.

Similarity: 74.9%

Buprenorphine

BUPRENORPHINE

Rhodes Pharmaceuticals L.P.

Similarity: 74.9%

BUPRENORPHINE

BUPRENORPHINE

NuCare Pharmaceuticals,Inc.

Similarity: 74.9%

BUPRENORPHINE

BUPRENORPHINE

Clinical Solutions Wholesale, LLC

Similarity: 74.9%

Buprenorphine

BUPRENORPHINE

Sun Pharmaceutical Industries, Inc.

Similarity: 74.9%

BUPRENORPHINE

BUPRENORPHINE

Rhodes Pharmaceuticals L.P.

Similarity: 74.9%

Buprenorphine and Naloxone

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Akorn Operating Company LLC (dba Akorn)

Similarity: 65.4%

Zubsolv

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Orexo US, Inc.

Similarity: 65.4%

Methadone Hydrochloride

METHADONE HYDROCHLORIDE

Hikma Pharmaceuticals USA Inc.

Similarity: 62.5%

Oxycodone Hydrochloride Oral Solution

OXYCODONE HYDROCHLORIDE ORAL SOLUTION

Aurolife Pharma, LLC

Similarity: 60.6%

Butorphanol Tartrate

BUTORPHANOL TARTRATE

Hospira, Inc.

Similarity: 60.2%

Butorphanol Tartrate

BUTORPHANOL TARTRATE

Hikma Pharmaceuticals USA Inc.

Similarity: 60.2%

Butorphanol Tartrate

BUTORPHANOL TARTRATE

Hikma Pharmaceuticals USA Inc.

Similarity: 60.2%